Using Facebook to help American Indian women recover from opioid use
Official title: Facebook Intervention for Preventing Opioid Relapse Among American Indian Women: Wiidookaage'Win Pilot Preparatory Study (Aim 2)
Run by Mayo Clinic · NCT05995886 · Data updated 2026-11-12
This study is testing whether a Facebook group can help American Indian women who are recovering from opioid use feel more supported and connected during their recovery journey.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 60 (estimated) |
| Sponsor | Mayo Clinic Academic / other |
| Locations | 1 site (Rochester, Minnesota) |
| Status | Recruiting |
| Started | October 16, 2023 |
| Main results expected | October 15, 2026 |
| Study ends | October 31, 2026 |
| Registry record updated | November 3, 2026 |
| Trial ID | NCT05995886 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are American Indian or Alaska Native women aged 18 and older who have been abstinent from opioids for at least one month and are currently using medication for opioid use disorder.
✕Probably not a fit
Patients who are currently experiencing suicidality or do not have access to the internet or a Facebook account may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to determine the effectiveness of a Facebook group designed to support American Indian women in their recovery from opioid use disorder. Participants will engage in a community-based intervention that leverages social media to foster connection and support among individuals in recovery. The study will include women who self-identify as American Indian or Alaska Native, are at least 18 years old, and have been abstinent from opioids for at least one month. The intervention will last for three months, during which participants will have access to resources and peer support through the Facebook group.
Why it matters
Potential benefit: If successful, this intervention could provide a valuable support network for American Indian women recovering from opioid use disorder.
How similar studies have gone: Other studies have shown promise in using social media for support in recovery, indicating that this approach may be effective, though this specific intervention is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. AIAN person based on self-reported race/ethnicity 2. Gender identity as a woman 3. At least 18 years of age with no upper age limit 4. Resides in Minnesota 5. Meets criteria for OUD based on the DSM-5 Checklist (American Psychiatric Association, 2013) 6. Self-reports at least one month of abstinence from opioid use based on TLFB interview and negative urine opiate screen 7. Current use of MOUD 8. Is comfortable speaking and reading English 9. Has an existing Facebook account or willing to set one up 10. Is willing and able to participate in the Facebook intervention for 3 months 11. Has access to broadband internet on a mobile phone/computer/tablet at any location 12. Is willing and able to travel to a community clinic in Minneapolis, Minnesota for the UDS or is willing to and able to complete a virtual Zoom UDS visit. 13. Provides written informed consent Exclusion Criteria: 1. Self-reports current suicidality based on the Concise Heath Risk Tracking scale 2. Participated in prior study phases (Aim 1 formative work) of NIDA CTN-0123
Where it's running
-
Mayo Clinic
Rochester, Minnesota, United States Recruiting
Study contacts
- Principal investigator: Christi A Patten, PhD — Mayo Clinic
- Study coordinator: Ashley Brown
- Email: wiidookaagewin@mayo.edu
- Phone: 1-833-880-2600
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
CBD for Opioid Dependence and Pain on Buprenorphine
This study tests whether different doses of cannabidiol (CBD) can affect pain and opioid cravings in adults with opioid use disorder who are on buprenorphine, using a short, randomized, placebo-controlled setup.
-
Cebranopadol for opioid withdrawal in adults with chronic pain
This study tests whether cebranopadol can reduce withdrawal symptoms in adults with chronic pain who are physically dependent on prescribed opioids, compared with placebo.
-
emPath platform pilot to link and keep adults with opioid use disorder in care in Durham
This pilot tests a mobile app and telemedicine approach to help adults with opioid use disorder start and stay in MOUD through community outreach in Durham, NC.
-
CB1 Receptors in Opioid Use Disorder Measured with a PET Radioligand
This study tests CB1 receptor availability in people with opioid use disorder starting opioid agonist therapy and compares them with healthy adults.
-
STORC: Training a support person plus patient navigation after birth
We’re testing whether training a designated support person and using patient navigation after delivery helps people with opioid use disorder build recovery resources and stay in treatment.
-
Personalized Addiction Treatment Enhancement for Opioid Use Disorder
A digital platform run by peer recovery supporters will be tested to help adults with opioid use disorder who are on buprenorphine or methadone stay in treatment and improve outcomes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.